Upregulation of Mrps18a in breast cancer identified by selecting phage antibody libraries on breast tissue sections

BMC Cancer - 2017
Karen Marie Juul Sørensen1, Theresa Meldgaard1, Connie Jenning Melchjorsen1, Agla J. Fridriksdottir2, Henrik Pedersen1, Ole William Petersen2, Peter Kristensen1
1Department of Engineering, Aarhus University, Aarhus, Denmark
2Department of Cellular and Molecular Medicine, Centre for Biological Disease Analysis and Danish Stem Cell Centre, University of Copenhagen, Copenhagen, Denmark

Tóm tắt

One of the hallmarks of cancer is an altered energy metabolism, and here, mitochondria play a central role. Previous studies have indicated that some mitochondrial ribosomal proteins change their expression patterns upon transformation. In this study, we have used the selection of recombinant antibody libraries displayed on the surface of filamentous bacteriophage as a proteomics discovery tool for the identification of breast cancer biomarkers. A small subpopulation of breast cells expressing both cytokeratin 19 and cytokeratin 14 was targeted using a novel selection procedure. We identified the mitochondrial ribosomal protein s18a (Mrps18a) as a protein which is upregulated in breast cancer. However, Mrps18a was not homogeneously upregulated in all cancer cells, suggesting the existence of sub-populations within the tumor. The upregulation was not confined to cytokeratin 19 and cytokeratin 14 double positive cells. This study illustrates how phage display can be applied towards the discovery of proteins which exhibit changes in their expression patterns. We identified the mitochondrial protein Mrps18a as being upregulated in human breast cancer cells compared to normal breast cells.

Từ khóa


Tài liệu tham khảo

World Cancer Report 2014. Edited by Stewart BW, Wild CP. International Agency for Research and Cancer. Lyon: World Health Organisation. 2014.

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

Deus CM, Coelho AR, Serafim TL, Oliveira PJ. Targeting mitochondrial function for the treatment of breast cancer. Future Med Chem. 2014;6(13):1499–513.

Cavdar Koc E, Burkhart W, Blackburn K, Moseley A, Spremulli LL. The small subunit of the mammalian mitochondrial ribosome. Identification of the full complement of ribosomal proteins present. J Biol Chem. 2001;276(22):19363–74.

Suzuki T, Terasaki M, Takemoto-Hori C, Hanada T, Ueda T, Wada A, Watanabe K. Proteomic analysis of the mammalian mitochondrial ribosome. Identification of protein components in the 28 S small subunit. J Biol Chem. 2001;276(35):33181–95.

Greber BJ, Bieri P, Leibundgut M, Leitner A, Aebersold R, Boehringer D, Ban N. Ribosome. The complete structure of the 55S mammalian mitochondrial ribosome. Science. 2015;348(6232):303–8.

Koc EC, Haque ME, Spremulli LL. Current views of the structure of the mammalian mitochondrial ribosome. Isr J Chem. 2010;50:45–59.

Kashuba E, Pavan Yenamandra S, Darekar SD, Yurchenko M, Kashuba V, Klein G, Szekely L. MRPS18-2 protein immortalizes primary rat embryonic fibroblasts and endows them with stem cell-like properties. Proc Natl Acad Sci U S A. 2009;106(47):19866–71.

Yenamandra SP, Darekar SD, Kashuba V, Matskova L, Klein G, Kashuba E. Stem cell gene expression in MRPS18-2-immortalized rat embryonic fibroblasts. Cell Death Dis. 2012;3:e357.

Shevchuk Z, Yurchenko MY, Darekar SD, Holodnuka-Kholodnyuk I, Kashuba VI, Kashuba EV. Overexpression of MRPS18-2 in Cancer Cell Lines Results in Appearance of Multinucleated Cells. Acta Nat. 2013;5(1):85–9.

Visvader JE, Stingl J. Mammary stem cells and the differentiation hierarchy: Current status and perspectives. Genes Dev. 2014;28(11):1143–58.

Visvader JE. Cells of origin in cancer. Nature. 2011;469(7330):314–22.

Honeth G, Schiavinotto T, Vaggi F, Marlow R, Kanno T, Shinomiya I, Lombardi S, Buchupalli B, Graham R, Gazinska P, et al. Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule. Stem Cell Rep. 2015;4(4):699–711.

Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, Gudjonsson T, Rank F, LaBarge MA, Bissell MJ, Petersen OW. Evidence for a stem cell hierarchy in the adult human breast. J Cell Biol. 2007;177(1):87–101.

Larsen SA, Meldgaard T, Lykkemark S, Mandrup OA, Kristensen P. Selection of cell-type specific antibodies on tissue-sections using phage display. J Cell Mol Med. 2015;19(8):1939–48. doi:10.1111/jcmm.12568.

Larsen SA, Meldgaard T, Fridriksdottir AJ, Lykkemark S, Poulsen PC, Overgaard LF, Petersen HB, Petersen OW, Kristensen P. Selection of a breast cancer subpopulation-specific antibody using phage display on tissue sections. Immunol Res. 2015;62(3):263–72. doi:10.1007/s12026-015-8657-x.

Sorensen MD, Agerholm IE, Christensen B, Kolvraa S, Kristensen P. Microselection—affinity selecting antibodies against a single rare cell in a heterogeneous population. J Cell Mol Med. 2010;14(7):1953–61.

Sorensen MD, Kristensen P. Selection of antibodies against a single rare cell present in a heterogeneous population using phage display. Nat Protoc. 2011;6(4):509–22.

Sorensen MD, Melchjorsen CJ, Mandrup OA, Kristensen P. Raising antibodies against circulating foetal cells from maternal peripheral blood. Prenat Diagn. 2013;33(3):284–91.

McCafferty J, Griffiths AD, Winter G, Chiswell DJ. Phage antibodies: filamentous phage displaying antibody variable domains. Nature. 1990;348(6301):552–4.

Ronnov-Jessen L, Petersen OW. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest. 1993;68(6):696–707.

Mandrup OA, Friis NA, Lykkemark S, Just J, Kristensen P. A novel heavy domain antibody library with functionally optimized complementarity determining regions. PLoS One. 2013;8(10):e76834.

Larsen SA, Meldgaard T, Fridriksdottir AJ, Lykkemark S, Poulsen PC, Overgaard LF, Petersen HP, Petersen OW, Kristensen P. Selection of breast cancer specific antibodies using phage display on tissue-sections. J Mol Oncol. 2014. Accepted.

Kristensen P, Winter G. Proteolytic selection for protein folding using filamentous bacteriophages. Fold Des. 1998;3(5):321–8.

Barbas CF, Burton DR, Scott JK, Silverman GJ. Phage Display: A Laboratory Manual. New York: Cold Spring Harbor Laboratory Press, 2001.

Jensen KB, Jensen ON, Ravn P, Clark BF, Kristensen P. Identification of keratinocyte-specific markers using phage display and mass spectrometry. Mol Cell Proteomics. 2003;2(2):61–9.

Sorensen MD, Gonzalez Dosal R, Jensen KB, Christensen B, Kolvraa S, Jensen UB, Kristensen P. Epsilon haemoglobin specific antibodies with applications in noninvasive prenatal diagnosis. J Biomed Biotechnol. 2009;2009:659219.

Jorgensen ML, Friis NA, Just J, Madsen P, Petersen SV, Kristensen P. Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae. Microb Cell Factories. 2014;13:9.

Wu Y, Li Q, Chen XZ. Detecting protein-protein interactions by Far western blotting. Nat Protoc. 2007;2(12):3278–84.

Lyng H, Brovig RS, Svendsrud DH, Holm R, Kaalhus O, Knutstad K, Oksefjell H, Sundfor K, Kristensen GB, Stokke T. Gene expressions and copy numbers associated with metastatic phenotypes of uterine cervical cancer. BMC Genomics. 2006;7:268.

Chen Y, Cairns R, Papandreou I, Koong A, Denko NC. Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One. 2009;4(9):e7033.

Saini N, Baihara J, Adlakha YK, Singh N. S29 ribosomal protein induces mitochondria mediated apoptosis of Hep2 cells via the activation of p38 MAPK and JNK signaling. Int J Integr Biol. 2009;5(1):49–57.

Khanna N, Sen S, Sharma H, Singh N. S29 ribosomal protein induces apoptosis in H520 cells and sensitizes them to chemotherapy. Biochem Biophys Res Commun. 2003;304(1):26–35.

Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G. EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes. Proc Natl Acad Sci U S A. 2008;105(14):5489–94.